One in Six Physician Mothers Provide Care to Other People
A new study found that physician mothers commonly have responsibilities outside of their children and patients—and that such burdens are linked to more anxiety and burnout.
Read More
New Arthritis Assay Tracks Early Antibody Formation Biomarker
An assay designed to track TNF counts in recently-treated RA patients found that early reduction of the protein could indicate future problems for the patient.
FDA Approves First Advair Diskus Generic
The Mylan product has been approved as 3 different dosing strengths, inidicated for both asthma and COPD care.
New Aripiprazole Patients Not at Worse Risk for Self-Harm, Hospitalization
A new cohort analysis shows patients switching or adding on the antipsychotic drug are not at a worse risk of suicide or other adverse events.
FDA Announces Record Rate of Novel Device Approvals in 2018
In the past 5 years, the administration has continually improved on the previous year's rate. More of the same should be anticipated in 2019.
Antibiotics Linked To Increased Hospital Stay for Exacerbated Asthmatics
Patients hospitalized for exacerbations due to asthma have a 29% longer stay if treated early with antibiotics.
Maria Sophocles, MD: Non-Invasive Options for Endometriosis
The painful condition requires more options for women to recover without further discomfort.
Benzodiazepine Visits Have Doubled, Co-Prescription with Opioids Have Quadrupled
A new study found the biggest burden of benzodiazepine-related visits have come from primary care physicians, and that efforts to limit sedative prescription may have to start there.
Omega-3 Shows No Benefit For Obese Pediatric Asthma Control
Obese/overweight patients aged 12 to 25 years old with uncontrolled asthma reported no significant improvements in asthma control compared to patients treated with soy oil control.
FDA Grants Marketing to STI Assay
A new test for Mycoplasma genitalium showed near-perfect rates of detection in non-infected patient samples.
FDA To Consider Pifeltro, Delstrigo as HIV Switch-On Therapies
The FDA will decide this year whether the once-daily Merck therapies can be marketed as a switch-on drug for patients with suppressed HIV-1.
Hepatitis C Therapy Not Linked to Liver Cancer Recurrence
Investigators are now interested in assessing potential benefits of direct-acting antivirals for HCV patients who previously had liver cancer.
FDA Clears Gene Therapy for Huntington Disease Assessment
An Investigational New Drug application was approved to clinically assess AMT-130 as the first potential drug marketed for the neurodegenerative disease.
Maria Sophocles, MD: Treating Mental Health in Menopausal Women
Why certain age-related factors particularly impact the mental health of women at the age their menopause symptoms appear.
Maria Sophocles, MD: Treating Symptoms of Menopause
What are the most overlooked, difficult-to-treat symptoms within menopause?
Sotagliflozin Receives Split Vote From FDA Advisory Committee
The investigative SGLT1/2 dual inhibitor is scheduled to be considered for marketing approval by mid-March.
Death Rates Due to Adverse Effects of Medical Treatment Decreasing in the US
University of Washington investigators found great disparities in AEMT-driven death rates among states and age groups.
Novavax Nears Maternal Immunization Results for RSV Vaccine
A four-year trial assessing the investigative vaccine in about 3000 pregnant women will announce efficacy results later this quarter.
Actelion Receives CRL for Macitentan CTEPH Indication
The FDA has responded to the Janssen Pharmaceutical company's sNDA with a request for more data.
Michael Thase, MD: Cariprazine and Current Bipolar Therapies
The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.
FDA Approves Tdap Booster Vaccine
The repeated dose vaccine from Sanofi Pasteur was assessed in 1300-plus patients aged 18 to 64. Currently, about 75% of US adults have not received a Tdap vaccination.
FDA Approves RAPID for Selecting Thrombectomy-Eligible Stroke Patients
The imaging platform is now the only of its kind approved for optimizing blood clot removal in the US.
Maria Sophocles, MD: Educating Patients on Conception
Why it's critical for physicians to remember that patients may not be as well-versed on the particularities of conceiving a child.
Maria Sophocles, MD: The Lone Female Sexual Dysfunction Therapy
Flibanserin, a once-daily oral drug, is the only marketed therapy for female sexual dysfunction. Are more options needed?
Half of Adolescents, Young Adults Get Private Time with Physicians
A new study finds that age, gender, physician gender, income, and social behavior influence whether teenagers and young adults are confidential with their care providers.
Mobile App Could Detect Opioid Overdoses Through Breathing
The Second Chance app from University of Washington investigators is seeking FDA consideration in the near future.
Mobile App-Friendly Digital Inhaler Could Improve Asthma, COPD Care
The ProAir Digihaler, from Teva, will reach the US markets widescale in 2020 after receiving FDA approval.
Maria Sophocles, MD: Why Female Sexual Dysfunction Therapy is Lacking
There is currently just 1 FDA-approved therapy for women suffering from dysfunction. What's driving the disparity?
Maria Sophocles, MD: The Challenges, Symptoms of Sexual Dysfunction
Why obstetricians and gynecologists need to consider the stigmas and telling signs of sexual dysfunction in female patients.
At Least 1 in 10 US Adults Suffer From Food Allergies
A new survey study found that less than half of food allergies reported by adults have actually been diagnosed by a physician.